Skip to main content

Table 2 Time points for radiographic imaging, clinical exams, and CTCAE an PRO collection during treatment and follow-up in ROAR-A. * Patients with T1-T2/N0 disease do not recieve FDG PET/CT and MRI during follow up unless a clinical exam warrants it

From: ROAR-A: re-optimization based Online Adaptive Radiotherapy of anal cancer, a prospective phase II trial protocol

 

Baseline

Mid treatment

End of treatment

1 month

3 months

12 months

24 months

60 months

CTCAE

X

X

X

X

X

X

X

X

PRO

X

X

X

X

X

X

X

X

MRI in sub study

X

X

X

     

FDG-PET/CT

X

   

X*

X*

X*

X*

MRI

    

X*

X*

X*

X*

Clinical exam

X

   

X

X

X

X

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us